From Crowdfunding to the Stock Market: GenXone’s Roadmap to NewConnect | Michał Kaszuba, CEO, GenXone SA. 00:10:00
Michał Kaszuba is the CEO of GenXone, a biotechnology company in Poland that specializes in molecular diagnostics and genetic sequencing. He has led GenXone in advancing innovative diagnostic methods, particularly through the use of nanopore sequencing technology. Under Kaszuba’s guidance, GenXone has developed capabilities in genomic testing that support fields like infectious disease research, which gained prominence as the company contributed to SARS-CoV-2 variant identification in Poland.
